Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017-Reference-Cited by-同舟云学术

Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017

Published:2022-09-20 Issue:9 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Westercamp Nelli¹^ORCID,Owidhi Mary²,Otieno Kephas²,Chebore Winnie²,Buff Ann M.¹³,Desai Meghna¹,Kariuki Simon²^ORCID,Samuels Aaron M.¹

Affiliation:

1. Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

2. Malaria Branch, Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya

3. U.S. President’s Malaria Initiative, Nairobi, Kenya

Abstract

Antimalarial resistance threatens global malaria control efforts. The World Health Organization (WHO) recommends routine antimalarial efficacy monitoring through a standardized therapeutic efficacy study (TES) protocol.

Funder

USAID | U.S. President's Malaria Initiative

HHS | Centers for Disease Control and Prevention

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.00207-22

Reference48 articles.

1. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015

2. World Trade Report 2018